HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease

Clinical trial NCT05865990 · COMPLETED

Trial details

NCT number: NCT05865990
Sponsor: MedSIR
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer Advanced Non-Small Cell Squamous Lung Cancer Solid Tumor, Adult

Start date: 2023-11-24
Primary completion: 2024-11-29
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.